Key facts
- Vivo Capital is a venture capital firm based in Palo Alto, California with 22 tracked portfolio companies.
- Notable positions include Tebra Technologies, 35Pharma, Avistone Pharmaceuticals Biotechnology.
- The team roster lists 2 people.
- Vivo Capital reports $418.6M in regulatory assets under management across 16 private funds, per its SEC Form ADV (2026-03).
About Vivo Capital
Founded in 1996, Vivo Capital is a venture capital firm based in Palo Alto, California. The firm seeks to invest globally in biopharmaceuticals, specialty pharmaceuticals, medical devices, and other subsectors of the healthcare and life sciences sectors. This firm is a Registered Investment Adviser (RIA).
Registered with the SEC
Form ADV · 2026-03 · CRD 159868- Regulatory AUM
- $418.6M
- Private fund assets
- $6.5B
- Private funds
- 16 · 6 venture, 6 private equity, 3 other
- Staff
- 62
- Registered office
- PALO ALTO, CA
- SEC status
- Approved
Reports custody of client assets.
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as VIVO CAPITAL LLC).
Free account
See more of the book
- ·The top 10 names in the book — of 22 recorded positions
- ·Watchlist + alerts for Vivo Capital's activity
Create free account
No card required
Portfolio
22 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Tebra Technologies | — | ▮ | ▮ | ▮ |
| 35Pharma | — | ▮ | ▮ | ▮ |
| Avistone Pharmaceuticals Biotechnology | — | ▮ | ▮ | ▮ |
+ 19 more companies · all 22, priced and dated or a free account shows the top 10 names — no card | ||||
Team
2 people on record — 2 with verified contacts
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked
- What companies does Vivo Capital invest in?
- Vivo Capital has 22 recorded portfolio companies, including Tebra Technologies, 35Pharma, Avistone Pharmaceuticals Biotechnology.
- What is Vivo Capital's AUM?
- Vivo Capital manages approximately $7.5B in assets.